Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| Age Differences | 1 |
| Attention Deficit… | 1 |
| Autism | 1 |
| Children | 1 |
| Disabilities | 1 |
| Drug Use | 1 |
| Outcomes of Treatment | 1 |
| Patients | 1 |
| Rating Scales | 1 |
| Teacher Evaluation | 1 |
| More ▼ | |
Source
| Journal of the American… | 1 |
Author
| Buitelaar, Jan K. | 1 |
| Escobar, Rodrigo | 1 |
| Harfterkamp, Myriam | 1 |
| Hoekstra, Pieter J. | 1 |
| Minderaa, Ruud B. | 1 |
| Pamulapati, Sireesha | 1 |
| Schacht, Alexander | 1 |
| van de Loo-Neus, Gigi | 1 |
| van der Gaag, Rutger-Jan | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
| Early Childhood Education | 1 |
| Elementary Education | 1 |
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkHarfterkamp, Myriam; van de Loo-Neus, Gigi; Minderaa, Ruud B.; van der Gaag, Rutger-Jan; Escobar, Rodrigo; Schacht, Alexander; Pamulapati, Sireesha; Buitelaar, Jan K.; Hoekstra, Pieter J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2012
Objective: The efficacy of atomoxetine as treatment of symptoms of attention-deficit/hyperactivity disorder (ADHD) in patients with autism spectrum disorder (ASD) has not been established. Method: In this study, 97 patients aged 6 to 17 years with ADHD and ASD were randomly assigned to double-blind treatment with 1.2 mg/kg/day atomoxetine or…
Descriptors: Attention Deficit Hyperactivity Disorder, Teacher Evaluation, Autism, Rating Scales
